These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 5482805)

  • 1. [Psychic disorders caused by pentazocine].
    Lassner J
    Presse Med (1893); 1970 Oct; 78(46):2010. PubMed ID: 5482805
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mental disorders induced by pentazocine].
    Alluaume R; Halpern G
    Presse Med (1893); 1970 Aug; 78(36):1577. PubMed ID: 5456289
    [No Abstract]   [Full Text] [Related]  

  • 3. Hallucinations following pentazocine. Case reports.
    Hansbrough ET
    Mo Med; 1970 Aug; 67(8):602 passim. PubMed ID: 5469859
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel side-effect of pentazocine.
    Jones KD
    Br J Clin Pract; 1975 Aug; 29(8):218. PubMed ID: 1164464
    [No Abstract]   [Full Text] [Related]  

  • 5. Mental and emotional disturbance with pentazocine (Talwin) use.
    Kane FJ; Pokorny A
    South Med J; 1975 Jul; 68(7):808-11. PubMed ID: 1154070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pentazocine].
    Flatberg P
    Tidsskr Nor Laegeforen; 1970 Sep; 90(18):1709. PubMed ID: 5458885
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Hallucinations from Pentazocine.
    Hemphill RE
    S Afr Med J; 1973 Oct; 47(42):1984. PubMed ID: 4755007
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: Mental side effects of pentazocine.
    Br Med J; 1974 Feb; 1(5903):297. PubMed ID: 4819146
    [No Abstract]   [Full Text] [Related]  

  • 9. Nitrous oxide for pentazocine addiction and for intractable pain: report of case.
    Kripke BJ; Hechtman HB
    Anesth Analg; 1972; 51(4):520-7. PubMed ID: 5064784
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of naloxone on pentazocine induced hallucinations.
    Jago RH; Restall J; Stonham J
    J R Army Med Corps; 1984 Feb; 130(1):64-5. PubMed ID: 6716360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pseudohallucinatory symptoms induced by pentazocin (Fortral). Case report].
    Tilz GP
    Munch Med Wochenschr; 1973 Apr; 115(16):699-700. PubMed ID: 4740413
    [No Abstract]   [Full Text] [Related]  

  • 12. Hallucinations associated with pentazocine.
    Edison GR
    N Engl J Med; 1969 Aug; 281(8):447-8. PubMed ID: 5797194
    [No Abstract]   [Full Text] [Related]  

  • 13. Central nervous disturbance with pentazocine.
    Gould WM
    Br Med J; 1972 Jan; 1(5795):313-4. PubMed ID: 5008496
    [No Abstract]   [Full Text] [Related]  

  • 14. Psychomimetic effects of pentazocine and dihydrocodeine tartrate.
    Taylor M; Galloway DB; Petrie JC; Davidson JF; Gallon SC; Moir DC
    Br Med J; 1978 Oct; 2(6146):1198. PubMed ID: 719349
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Central nervous system effects of pentazocine.
    Alexander JI; Spence AA
    Br Med J; 1974 Apr; 2(5912):224-5. PubMed ID: 4832250
    [No Abstract]   [Full Text] [Related]  

  • 16. The hallucinatory effect of pentazocine (Talwin).
    DeNosaquo N
    JAMA; 1969 Oct; 210(3):502. PubMed ID: 5394381
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pentazocine (Fortralin) suppositories].
    Naess K
    Tidsskr Nor Laegeforen; 1974 May; 94(15):1008-9. PubMed ID: 4840763
    [No Abstract]   [Full Text] [Related]  

  • 18. Pentazocine.
    Br Med J; 1970 May; 2(5706):409-11. PubMed ID: 5420610
    [No Abstract]   [Full Text] [Related]  

  • 19. Medicines evaluation and monitoring group: central nervous system effects of pentazocine.
    Wood AJ; Moir DC; Campbell C; Davidson JF; Gallon SC; Henney E; McAllion S
    Br Med J; 1974 Feb; 1(5903):305-7. PubMed ID: 4819152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hallucinosis in ephedrine addiction].
    Prokop H
    Nervenarzt; 1968 Feb; 39(2):71-5. PubMed ID: 5678234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.